These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 21465230)
1. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients. Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230 [TBL] [Abstract][Full Text] [Related]
2. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Nakamura S; Yagata H; Ohno S; Yamaguchi H; Iwata H; Tsunoda N; Ito Y; Tokudome N; Toi M; Kuroi K; Suzuki E Breast Cancer; 2010 Jul; 17(3):199-204. PubMed ID: 19649686 [TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer. Wallwiener M; Hartkopf AD; Baccelli I; Riethdorf S; Schott S; Pantel K; Marmé F; Sohn C; Trumpp A; Rack B; Aktas B; Solomayer EF; Müller V; Janni W; Schneeweiss A; Fehm TN Breast Cancer Res Treat; 2013 Jan; 137(2):503-10. PubMed ID: 23271327 [TBL] [Abstract][Full Text] [Related]
4. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556 [TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255 [TBL] [Abstract][Full Text] [Related]
6. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854 [TBL] [Abstract][Full Text] [Related]
7. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer. Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790 [TBL] [Abstract][Full Text] [Related]
8. Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients. Giordano A; Giuliano M; De Laurentiis M; Eleuteri A; Iorio F; Tagliaferri R; Hortobagyi GN; Pusztai L; De Placido S; Hess K; Cristofanilli M; Reuben JM Breast Cancer Res Treat; 2011 Sep; 129(2):451-8. PubMed ID: 21710134 [TBL] [Abstract][Full Text] [Related]
9. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556 [TBL] [Abstract][Full Text] [Related]
10. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients. Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023 [TBL] [Abstract][Full Text] [Related]
11. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance. Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323 [TBL] [Abstract][Full Text] [Related]
12. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712 [TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis. Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970 [TBL] [Abstract][Full Text] [Related]
15. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Sandri MT; Zorzino L; Cassatella MC; Bassi F; Luini A; Casadio C; Botteri E; Rotmensz N; Adamoli L; Nolè F Ann Surg Oncol; 2010 Jun; 17(6):1539-45. PubMed ID: 20135356 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462 [TBL] [Abstract][Full Text] [Related]
17. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Fehm T; Müller V; Aktas B; Janni W; Schneeweiss A; Stickeler E; Lattrich C; Löhberg CR; Solomayer E; Rack B; Riethdorf S; Klein C; Schindlbeck C; Brocker K; Kasimir-Bauer S; Wallwiener D; Pantel K Breast Cancer Res Treat; 2010 Nov; 124(2):403-12. PubMed ID: 20859679 [TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. Cristofanilli M; Hayes DF; Budd GT; Ellis MJ; Stopeck A; Reuben JM; Doyle GV; Matera J; Allard WJ; Miller MC; Fritsche HA; Hortobagyi GN; Terstappen LW J Clin Oncol; 2005 Mar; 23(7):1420-30. PubMed ID: 15735118 [TBL] [Abstract][Full Text] [Related]
19. Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy. Sandri MT; Johansson HA; Zorzino L; Salvatici M; Passerini R; Maisonneuve P; Rocca A; Peruzzotti G; Colleoni M Cancer; 2007 Aug; 110(3):509-17. PubMed ID: 17559147 [TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer. Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]